跳至主要内容
临床试验/NCT00167869
NCT00167869已完成2 期

LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Wageningen University2 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2004年6月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
135
试验地点
2
主要终点
Blood pressure

研究概览

简要总结

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • systolic blood pressure >= 140 mmHg
  • BMI between 18 and 32 kg/m2
  • apparently healthy

排除标准

  • antihypertensive medication
  • medically prescribed or slimming diet
  • lactating, pregnant
  • irregular pulse

结局指标

主要结局

Blood pressure

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

LACTOPRES:Study on the Effect of Dairy Peptides on... | 临床试验